Literature DB >> 11241275

Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries.

M Sioud1, M H Hansen.   

Abstract

Display on the surface of filamentous phages has been shown to be well suited for the enrichment of serum antibody-binding ligands. Here, we have taken the advantage of this technology to analyze the humoral immune response in patients with cancer. The cDNA repertoires from breast cancer cell lines T47D and MCF-7 were fused to the 3'-end of the filamentous phage M13 gene VI in all three reading frames. When the libraries were biopanned on rabbit polyclonal IgG against the human Bcl-x(L) protein, positive clones were selected, thus confirming the utility of the libraries. Using serum antibodies from patients with breast cancer, we specifically selected IgG-binding phage-encoded cDNA products. Sequence analysis of the selected clones identified important antigens including p53, centromere-F, int-2, pentraxin I, integrin beta5, cathepsin L2 and S3 ribosomal protein. The selected phage-displayed cDNA products were recognized by a significant number of breast cancer sera as compared to sera from normal individuals. Although the human pentraxin I mRNA was reported to be exclusively localized in the nervous system, we found it also expressed by breast cancer cell lines. Four out of 30 patients with breast cancer (13 %) showed reactivity with the recombinant pentraxin expressed in Escherichia coli, while no reactivity was found in normal sera. The obtained results demonstrate that phage display could be a valuable method for the identification of antigens recognized by the humoral immune system in patients with cancer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11241275     DOI: 10.1002/1521-4141(200103)31:3<716::aid-immu716>3.0.co;2-9

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  17 in total

1.  Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer.

Authors:  Karen S Anderson; Sahar Sibani; Garrick Wallstrom; Ji Qiu; Eliseo A Mendoza; Jacob Raphael; Eugenie Hainsworth; Wagner R Montor; Jessica Wong; Jin G Park; Naa Lokko; Tanya Logvinenko; Niroshan Ramachandran; Andrew K Godwin; Jeffrey Marks; Paul Engstrom; Joshua Labaer
Journal:  J Proteome Res       Date:  2010-11-23       Impact factor: 4.466

2.  Antibody repertoire profiling with mimotope arrays.

Authors:  Shina Pashova; Christoph Schneider; Stephan von Gunten; Anastas Pashov
Journal:  Hum Vaccin Immunother       Date:  2016-12-08       Impact factor: 3.452

Review 3.  Tumor-associated antigen arrays for the serological diagnosis of cancer.

Authors:  Carlos A Casiano; Melanie Mediavilla-Varela; Eng M Tan
Journal:  Mol Cell Proteomics       Date:  2006-05-29       Impact factor: 5.911

Review 4.  Therapeutic cancer vaccines and translating vaccinomics science to the global health clinic: emerging applications toward proof of concept.

Authors:  Megan M O'Meara; Mary L Disis
Journal:  OMICS       Date:  2011-07-06

Review 5.  The sentinel within: exploiting the immune system for cancer biomarkers.

Authors:  Karen S Anderson; Joshua LaBaer
Journal:  J Proteome Res       Date:  2005 Jul-Aug       Impact factor: 4.466

6.  Lung cancer-associated auto-antibodies measured using seven amino acid peptides in a diagnostic blood test for lung cancer.

Authors:  Nada H Khattar; Sarah P Coe-Atkinson; Arnold J Stromberg; James R Jett; Edward A Hirschowitz
Journal:  Cancer Biol Ther       Date:  2010-08-18       Impact factor: 4.742

7.  Using protein microarray as a diagnostic assay for non-small cell lung cancer.

Authors:  Li Zhong; Giovanna E Hidalgo; Arnold J Stromberg; Nada H Khattar; James R Jett; Edward A Hirschowitz
Journal:  Am J Respir Crit Care Med       Date:  2005-08-18       Impact factor: 21.405

Review 8.  Tumor vaccines for breast cancer.

Authors:  Karen S Anderson
Journal:  Cancer Invest       Date:  2009-05       Impact factor: 2.176

9.  Novel phage display-based subtractive screening to identify vaccine candidates of Brugia malayi.

Authors:  Munirathinam Gnanasekar; Kakaturu V N Rao; Yi-Xun He; Pankaj K Mishra; Thomas B Nutman; Perumal Kaliraj; Kalyanasundaram Ramaswamy
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

Review 10.  Autoantibodies to tumor-associated antigens: reporters from the immune system.

Authors:  Eng M Tan; Jianying Zhang
Journal:  Immunol Rev       Date:  2008-04       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.